SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Moellering RC, Krogstad DJ, Greenblatt DJ. Vancomycin therapy in patients with impaired renal function: a nomogram for dosage. Ann Intern Med 1981; 94: 3436.
  • 2
    Rybak M, Lomaestro B, Rotschafer RM, Craig W, Billeter M, Dalovisio JR, Levine DP. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009; 66: 8298.
  • 3
    Martin JH, Norris R, Barras M, Roberts J, Morris R, Doogue M, Jones GRD. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America and the Society of Infectious Diseases Pharmacists. Clin Biochem Rev 2010; 31: 214.
  • 4
    Bloudin RA, Bauer LA, Miller DD, Record KE, Griffen WO. Vancomycin pharmacokinetics in normal and morbidly obese subjects. Antimicrob Agents Chemother 1982; 21: 57580.
  • 5
    Vance-Bryan K, Guay DRP, Gilliland SS, Rodvold KA, Rotschafer JC. Effect of obesity on vancomycin pharmacokinetic parameters as determined by using Bayesian forecasting technique. Antimcrob Agents Chemother 1993; 37: 43640.
  • 6
    Tobin CM, Darville JM, Thomson AH, Sweeney G, Wilson JF, MacGowan AP, White LO. Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for antibiotic assays questionnaire. J Antimicrob Chemother 2002; 50: 7138.
  • 7
    Lodise TP, Lomaestro B, Graves J, Drusano GL. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother 2008; 52: 13306.
  • 8
    Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalised patients. Clin Infect Dis 2009; 49: 50714.
  • 9
    Solomon R, Bigori C, Bettmann M. Selection of contrast media. Kidney Int 2006; 69: S3945.
  • 10
    Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology and patients at risk. Kidney Int 2006; 69: S115.
  • 11
    Jones TE, Peter JV, Field J. Aminoglycoside clearance is a good estimate of creatinine clearance in intensive care unit patients. Anaesth Intensive Care 2009; 37: 94452.